The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Teplyuk D.A.
Sechenov First Moscow State Medical University;
Botkin Moscow City Hospital
Pavlov Ch.S.
Sechenov First Moscow State Medical University;
Botkin Moscow City Hospital
Autoimmune hepatitis: pitfalls of diagnosis and therapy (clinical case)
Journal: Russian Journal of Evidence-Based Gastroenterology. 2024;13(4): 95‑103
Views: 683
Downloaded: 81
To cite this article:
Avdyshev VD, Kharlamova AA, Kucher AE, et al. . Autoimmune hepatitis: pitfalls of diagnosis and therapy (clinical case). Russian Journal of Evidence-Based Gastroenterology.
2024;13(4):95‑103. (In Russ.)
https://doi.org/10.17116/dokgastro20241304195
Autoimmune hepatitis (AIH) is an immune-mediated chronic liver disease that can lead to cirrhosis and its complications. The lack of strict diagnostic criteria for AIH complicates diagnosis and delays the initiation of appropriate therapy. Treatment selection and patient management remain challenges.
To highlight the diagnostic and therapeutic aspects of AIH based on a clinical case.
A 33-year-old female presented with significant cytolysis and cholestasis. A differential diagnosis ruled out viral hepatitis, liver storage diseases, and drug-induced liver injury (the patient had taken paracetamol and amoxicillin-clavulanate for a recent viral infection). Anti-SLA/LP antibodies were detected, while ANA, AMA, ANCA, SMA, and anti-LKM were within reference ranges. A liver biopsy revealed features of AIH and grade 1 steatosis. The final diagnosis was chronic AIH with high cytolytic activity, intrahepatic cholestasis, and parenchymal jaundice. Immunosuppressive therapy with prednisolone (40 mg/day) and azathioprine (50 mg/day) was initiated, with dosage adjustments for side effects. Despite four years of therapy, full biochemical and morphological remission was not achieved, and the risk of cirrhosis remains. This case underscores the challenges of diagnosing AIH and its potential overlap with cholestatic liver diseases. The article also discusses the need to monitor therapy-related side effects and the role of thiopurine S-methyltransferase testing in treatment.
The heterogeneity of AIH symptoms complicates early diagnosis. A comprehensive approach, including autoantibody testing and imaging, is essential for timely and accurate diagnosis.
Authors:
Teplyuk D.A.
Sechenov First Moscow State Medical University;
Botkin Moscow City Hospital
Pavlov Ch.S.
Sechenov First Moscow State Medical University;
Botkin Moscow City Hospital
Received:
20.03.2024
Accepted:
08.10.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.